Home › Disorders of Excessive Somnolence › Florida
Disorders of Excessive Somnolence clinical trials in Florida
9 studies for Disorders of Excessive Somnolence are looking for participants at sites in Florida.
Cities in Florida
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Brandon, Florida, Brandon
- Miami, Florida, Miami
- Miami, Florida, Miami
- and 5 more
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Oct 2, 2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- PharmDev Research Institute, LLC, Miami
- Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC), Winter Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Maimi
- Alkermes Investigational Site, Winter Park
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07540897A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Brandon
- Alkermes Investigational Site, Miami
- Alkermes Investigational Site, Winter Park
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Jacksonville
- Clinical Research Site, Miami
- Clinical Research Site, Miami
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT07484217Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Brandon
- Clinical Research Site, Hialeah
- Clinical Research Site, Miami
- and 2 more
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT06568367A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Miami, Florida, Miami
- Orlando, Florida, Orlando
- Winter Park, FL, Winter Park
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.